Speaker illustration

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Heart Rythm Association

John Camm is Professor of Clinical Cardiology (emeritus) at St. George’s University of London. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, and risk stratification in post-myocardial infarction, heart failure, atrial fibrillation and cardiomyopathy patients. Professor Camm is a fellow of the European Society of Cardiology, and the European Heart Rhythm Association. He is past president of the European Heart Rhythm Association and president of the Arrhythmia Alliance, founder and trustee of the Atrial Fibrillation Association and trustee of the Drug Safety Research Unit. Professor Camm is Editor-in-Chief of the European Heart Journal Case Reports, Editor of European Heart Journal, immediate past Editor-in-Chief of EP Europace, He is also Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine and ESC CardioMed.

Great Debate: controversies in atrial fibrillation - early rhythm control and atrial fibrillation burden

Event: ESC Congress 2023

Topic: Clinical

Session type: Great Debates

Thumbnail

Exploring new frontiers to anticoagulate in atrial fibrillation (AF): update on AF burden and subclinical AF

Event: EHRA 2023

Topic: Oral Anticoagulation

Session type: Satellite Symposium

Thumbnail

AF burden: a unified concept for various clinical conditions

Event: EHRA 2023

Topic: Pathophysiology and Mechanisms

Session type: Satellite Symposium

Thumbnail

Late Breaking Science - Day 1

Event: EHRA 2023

Topic: Device Therapy

Session type: Late-Breaking Science

Thumbnail

Neurocardiology: hot topics in an emerging multidisciplinary specialty

Event: ESC Congress 2022

Topic: Stroke Treatment

Session type: Symposium

Thumbnail

Oral anticoagulation in real life

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session type: Moderated ePosters

Thumbnail

Screening for atrial fibrillation - a pro/con debate

Event: EHRA 2022

Topic: Clinical

Session type: Debate Session

Thumbnail

Hybrid ablation: a new standard of care in long standing persistent atrial fibrillation?

Event: EHRA 2022

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences

Event: EHRA 2022

Topic: Arrhythmias, General

Session type: Late-Breaking Science

Thumbnail

What if? Protecting your patients with NVAF from stroke, no matter their journey

Event: EHRA 2022

Topic: Stroke Prevention

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb